Potential public health impact of the adjuvanted recombinant zoster vaccine among people aged 50 years and older in Beijing

Herpes zoster (HZ) is a painful, unilateral rash which occurs upon reactivation of latent varicella zoster virus due to age-related immunity decline or immuno-suppression. In 2019, the recombinant zoster vaccine (RZV) was the first vaccine to be approved in China for HZ prevention. This study aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Christa, Jiang, Ning, Tang, Haiwen, Ye, Chiyu, Yuan, Yanfei, Curran, Desmond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437530/
https://www.ncbi.nlm.nih.gov/pubmed/34310268
http://dx.doi.org/10.1080/21645515.2021.1932216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437530/
https://www.ncbi.nlm.nih.gov/pubmed/34310268
http://dx.doi.org/10.1080/21645515.2021.1932216

Ejemplares similares